Fuquay-Varina, NC, United States of America

Stephen G Simkins

USPTO Granted Patents = 2 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
2 patents (USPTO):

Title: The Innovations of Stephen G. Simkins

Introduction

Stephen G. Simkins is a notable inventor based in Fuquay-Varina, North Carolina. He has made significant contributions to the field of medical diagnostics, particularly in the detection of ovarian cancer. With a total of two patents to his name, Simkins has developed innovative solutions that enhance the accuracy of cancer diagnosis.

Latest Patents

Simkins' latest patents focus on glycodelin monoclonal antibodies and their methods for use in the detection of ovarian cancer. These patents provide compositions and methods for diagnosing ovarian cancer in patients and for identifying those with an increased likelihood of having the disease. The compositions include novel monoclonal antibodies, as well as their variants and fragments, that specifically bind to glycodelin. Additionally, the patents disclose hybridoma cell lines that produce these antibodies, along with kits that incorporate the antibodies for practical use in diagnostic methods. The polypeptides comprising the amino acid sequence for a glycodelin epitope are also included, which can be utilized in the production of glycodelin antibodies.

Career Highlights

Stephen G. Simkins is currently associated with Tripath Imaging, Inc., where he continues to work on advancements in medical diagnostics. His expertise in the field has led to the development of innovative technologies that have the potential to improve patient outcomes in cancer detection.

Collaborations

Simkins has collaborated with notable colleagues, including Robert L. Cheek and Eric P. Dixon. These partnerships have contributed to the successful development of his patented technologies and have fostered a collaborative environment for innovation.

Conclusion

Stephen G. Simkins is a distinguished inventor whose work in glycodelin monoclonal antibodies represents a significant advancement in ovarian cancer diagnostics. His contributions to the field are invaluable and continue to impact medical research and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…